Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Quhan Zhiwang decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of rheumatoid arthritis (RA), specifically for patients presenting with the "kidney deficiency and excessive cold" syndrome. The decoction is designed to tonify the kidneys, dispel cold, and alleviate joint pain (a condition referred to in TCM as Wang Bi). It is typically used as an adjunctive therapy alongside conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) like methotrexate to help patients achieve deep clinical remission. Clinical studies, including those led by the China-Japan Friendship Hospital and Peking University, evaluate its efficacy using disease activity scores (DAS28), pain scales (VAS), and mechanical pain threshold measurements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bushen quhan zhiwang decoction.